Answers are grounded in this paper and cite their sources.
This research demonstrates biotransformation of benzoate to produce cis 2,3 dihydroxy 2,3 dihydrobenzoate, highlighting its potential as a chiral building block.
Bacterial Rieske non‐heme iron oxygenases catalyse the transformation of a wide range of aromatic compounds to vicinal cis ‐dihydrodiols. Such compounds have been successfully applied in chemoenzymatic synthetic routes for, for example, pharmaceuticals, natural products and polymers. In the case of benzoate, only (1 S ,2 R )‐ cis ‐1,2‐dihydroxy‐2‐hydrobenzoate is readily accessible via enzymatic transformation, but not the regioisomeric cis ‐2,3‐dihydroxy‐2,3‐dihydrobenzoate (2,3‐DD) or cis ‐3,4‐dihydroxy‐3,4‐dihydrobenzoate. While trace amounts of putative cis ‐2,3‐DD have been obtained before by using p ‐cumate 2,3‐dioxygenase (PCDO) or a combination of chlorobenzene dioxygenase and nitrilase, none of these approaches enabled its production and isolation at a greater scale for potential use as a chiral building block in organic synthesis. We here provide a protocol for biotransformation of benzoate yielding (2 R ,3 S )‐2,3‐dihydroxy‐2,3‐dihydrobenzoate using the PCDO of Pseudomonas citronellolis strain EB200 with negligible formation of side products. An isolation procedure suitable for production of the 2,3‐DD sodium salt monohydrate at high purity (> 95%) at a gram scale, and a comprehensive characterisation of this novel metabolite is given.
No takes yet. Share an insight, caveat, or question.
Kiel et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: